Latest filing published 13 Dec 2018 for KERYX BIOPHARMACEUTICALS INC, €30k.
This profile gathers the share dealings of Christine A. Carberry in Keryx Biopharmaceuticals Inc. The record holds 8 filings, for trades running from 17 January 2017 to 12 December 2018.
Every open-market trade on record is a sale: 5 sales worth €87k. Other entries cover 2 share grants. In 2018 alone, the filings show no purchases and 5 sales.
The record was last updated on 13 December 2018 with a transaction in Keryx Biopharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations